A Science and Technology Blog
With at least two months follow-up data likely to be available earliest only by November or December, the guidance essentially shuts the door on vaccine manufacturers making their vaccines available…
FDA grants emergency use authorisation for convalescent plasma even in the absence of evidence from randomised, controlled trial. Mr. Trump, FDA Commissioner and Secretary of Health and Human Services made…
If speed, low cost and constraints of molecular testing capacity are the reasons why many States have embraced rapid antigen testing, the test has low sensitivity. Yale University’s saliva test,…
On June 15, FDA revoked the emergency use authorisation for hydroxychloroquine and chloroquine that was issued on March 27. The FDA said it is no longer reasonable to believe that…
In new guidelines issued on May 6, WHO has backed human challenge studies for COVID-19 vaccines on the ground that it could both accelerate vaccine development and make the final…
ICMR’s insistence on an evidence-based approach to plasma therapy is a welcome change and is in stark contrast to the cavalier manner in which it approved hydroxychloroquine as a prophylaxis…
Results of a randomised, control trial using hydroxychloroquine drug in 150 COVID-19 patients show that the drug does not reduce the viral load even on day 28. However, patients who…
Given the circumstances, it would be difficult to believe that the decision to lift the restriction was taken independent of U.S. pressure. But the pandemic has seen several countries displaying…
